|
Index of reports
> Cases resulting in a serious event (100)
> Cases with Interstitial Lung Disease (13)
Below is the selection of adverse event reports related to Tenormin (Atenolol) that includes cases resulting in a serious event where reactions include interstitial lung disease.
Adverse event in 68 year old male receiving Tenormin (Atenolol)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-27
Patient: 68 year old male
Adverse reactions / side effects: Multi-Organ Failure, Drug Ineffective, Interstitial Lung Disease, Alveolitis Allergic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cordarone
Dosage: 300 mg
Indication: Atrial Fibrillation
Start date: 2007-04-09
End date: 2007-04-09
Cordarone
Dosage: 3 vials
Start date: 2007-04-14
End date: 2007-04-14
Cordarone
Dosage: 6 vials
Start date: 2007-04-15
End date: 2007-04-15
Cordarone
Dosage: 1 vial
Start date: 2007-04-16
End date: 2007-04-18
Cordarone
Dosage: not provided
Start date: 2007-04-10
End date: 2007-04-13
Tenormin
Dosage: 2 mg once
Indication: Atrial Fibrillation
Start date: 2007-04-09
End date: 2007-04-09
Other drugs received by patient: Tazocilline; Tazocilline; Amikacin
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-06-20
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in 68 year old male receiving Tenormin (Atenolol)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-14
Patient: 68 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cordarone
Indication: Atrial Fibrillation
Start date: 2007-04-09
End date: 2007-04-09
Cordarone
Start date: 2007-04-14
End date: 2007-04-14
Cordarone
Start date: 2007-04-15
End date: 2007-04-15
Cordarone
Start date: 2007-04-16
End date: 2007-04-18
Tenormin
Indication: Atrial Fibrillation
Start date: 2007-04-09
End date: 2007-04-09
Other drugs received by patient: Diprivan; Diprivan; Crestor; Kardegic; Kardegic; Isoptin; Sufenta; Sufenta; Tracrium; Tracrium; Tazocilline; Tazocilline; Amiklin
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-05-23
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-04-26
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in 68 year old male receiving Tenormin (Atenolol)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-04
Patient: 68 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Tenormin (Atenolol)
Other drugs received by patient: Kardegic; Perindopril Erbumine; Zocor; Plavix; Amlor
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-03-27
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in 73 year old female receiving Tenormin (Atenolol)
Reported by a physician from France on 2007-03-07
Patient: 73 year old female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Tenormin (Atenolol)
Other drugs received by patient: Renitec
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-08
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-01-19
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Suspect drug(s):
Micardis
Administration route: Oral
Norvasc
Administration route: Oral
Tenormin
Administration route: Oral
|
